Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trialStefan Groeneweg, W. Edward Visser, Françoise Auriol et al.|The Lancet Diabetes & Endocrinology|2019Cited by 126
Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trialStefan Groeneweg, Visser WE, Robin P. Peeters et al.|Yearbook of pediatric endocrinology|2020Cited by 2